Osborne Clarke advised Creo Europe on the deal. Micro-Tech Nanjing, a Chinese producer of minimally invasive medical devices, acquired a controlling stake (51%) of Creo Medical...
Micro-Tech’s Acquisition Of 51% Stake In Creo Medical
Innomy Labs’ $1.3 Million Round Funding
CLO I Cornu Labat – Otálvares Abogados advised Innomy Labs on the transaction. Osborne Clarke advised Corporación Cerviño on the transaction Innomy Labs executed a $1.3 million...